Abstract
Hypokalemic periodic paralysis is a rare disorder characterized by episodic attacks of muscle flaccidity associated with low serum potassium levels. We report twelve patients with normokalemic and hypokalemic periodic paralysis due to various mutations who developed hypokalemic paralytic episodes following a single dose or short-term administration of glucocorticoids. We hypothesize that glucocorticoids cause hypokalemia due to their stimulation of the Na(+)-K(+) ATPase mediated by insulin and amylin and due to their side effect of insulin resistance resulting in hyperglycemia. This report adds to the clinical description of glucocorticoids as a trigger of attacks of hypokalemic periodic paralysis indicating that glucocorticoids should be administered with caution in patients with periodic paralysis.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Amyloid / metabolism
-
DNA Mutational Analysis
-
Female
-
Genetic Predisposition to Disease / genetics
-
Genotype
-
Glucocorticoids / adverse effects*
-
Humans
-
Hyperglycemia / chemically induced
-
Hyperglycemia / metabolism
-
Hyperglycemia / physiopathology
-
Hypokalemic Periodic Paralysis / chemically induced*
-
Hypokalemic Periodic Paralysis / genetics
-
Hypokalemic Periodic Paralysis / physiopathology*
-
Insulin / metabolism
-
Insulin Resistance / physiology
-
Insulin Secretion
-
Ion Channels / drug effects
-
Ion Channels / metabolism
-
Islet Amyloid Polypeptide
-
Male
-
Muscle, Skeletal / drug effects*
-
Muscle, Skeletal / metabolism
-
Muscle, Skeletal / physiopathology*
-
Mutation / genetics
-
Potassium / analysis
-
Potassium / blood*
-
Retrospective Studies
-
Sex Distribution
-
Sodium-Potassium-Exchanging ATPase / drug effects
-
Sodium-Potassium-Exchanging ATPase / metabolism
-
Young Adult
Substances
-
Amyloid
-
Glucocorticoids
-
Insulin
-
Ion Channels
-
Islet Amyloid Polypeptide
-
Sodium-Potassium-Exchanging ATPase
-
Potassium